Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Maravai LifeSciences Holdings, Inc. - Class A common stock (NQ:MRVI)

3.140 +0.050 (+1.62%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Maravai LifeSciences Holdings, Inc. - Class A common stock

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
News headline image
Sail Through the Choppy Market With These 4 Low-Beta Stocks ↗
Creating a portfolio of low-beta stocks is important since the securities can deliver healthy returns and provide a shield against volatile market conditions. 
Via Talk Markets
News headline image
Maravai LifeSciences Rejects Sartorius' $11B Takeover Bid: Reuters ↗
Germany-based laboratory equipment supplier Sartorius AG has approached Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) with an $11 billion acquisition offer... 
Via Benzinga
News headline image
Maravai LifeSciences: Q4 Earnings Insights ↗
Maravai LifeSciences (NASDAQ:MRVI) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:00 PM. Here's what investors need to know about the announcement.... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Kodiak's Wet AMD Treatment KSI-301 Did Not Meet Primary Endpoint In Phase... 
Via Benzinga
News headline image
Maravai LifeSciences - Pick Of The Day ↗
Healthcare company Maravai's stock hit 18 new highs and is up 51.06% in the last month. 
Via Talk Markets
News headline image
The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
News headline image
Earnings Scheduled For February 23, 2022 ↗
Companies Reporting Before The Bell • Sapiens Intl Corp (NASDAQ:SPNS) is likely to report earnings for its fourth quarter. • Plymouth Industrial REIT (NYSE:PLYM)... 
Via Benzinga
News headline image
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow ↗
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front... 
Via Benzinga
News headline image
Maravai Lifesciences Stock Closes In Technical Benchmark, Hitting 80-Plus RS Rating ↗
One key metric to look for in a stock is 80-plus RS Rating. Maravai Lifesciences stock just hit that mark, with a jump from 71 to 81 Monday. 
Via Investor's Business Daily
News headline image
56 Biggest Movers From Friday ↗
Gainers iSpecimen Inc. (NASDAQ: ISPC) climbed 71.7% to settle at $17.51 on Friday. The company recently announced it has been contracted to support new advanced research on... 
Via Benzinga
News headline image
Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2021 Earnings Call Transcript ↗
MRVI earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
54 Biggest Movers From Friday ↗
Check out these big penny stock gainers and losers Losers Spire Global, Inc.. (NYSE: SPIR) shares fell 43.3% to close at $7.10 on Friday. Spire Global, Inc.... 
Via Benzinga
News headline image
48 Stocks Moving In Friday's Mid-Day Session ↗
Gainers Allied Healthcare Products, Inc. (NASDAQ: AHPI) shares jumped 68% to $9.04. Shares of mask and protective apparel companies, including Allied Healthcare Products, traded... 
Via Benzinga
News headline image
Why Maravai LifeSciences Tumbled Nearly 12% Today ↗
A private equity firm and several peers are cashing out of a pile of shares. 
Via The Motley Fool
News headline image
41 Stocks Moving In Friday's Mid-Day Session ↗
Gainers IVERIC bio, Inc. (NASDAQ: ISEE) shares climbed 64.4% to $14.29 after Apellis Pharmaceuticals reported results from its Phase 3 DERBY and OAKS studies in geographic... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus MorphoSys COO To Leave To Pursue Other Opportunities MorphoSys AG (NASDAQ:... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Gainers IVERIC bio (NASDAQ:ISEE) stock increased by 65.36% to $14.37 during Friday's pre-market session. The company's market cap stands at $1.4 billion. T2... 
Via Benzinga
News headline image
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More ↗
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out... 
Via Benzinga
News headline image
20 Stocks Moving in Friday's Pre-Market Session ↗
Gainers IVERIC bio, Inc. (NASDAQ: ISEE) rose 29.6% to $11.26 in pre-market trading. Iveric Bio recently reported inducement grants under Nasdaq Listing Rule 5635(c)(4). T2... 
Via Benzinga
News headline image
92 Biggest Movers From Friday ↗
Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares jumped 99.8% to close at $9.99 on Friday. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the... 
Via Benzinga
News headline image
60 Biggest Movers From Friday ↗
Gainers IVERIC bio, Inc. (NASDAQ: ISEE) shares surged 62.5% to close at $14.12 on Friday after Apellis Pharmaceuticals reported results from its Phase 3 DERBY and OAKS studies in... 
Via Benzinga
News headline image
Maravai Offloads Vector Labs To Private Equity ↗
Thompson Street Capital Partners, a private equity firm, has acquired Vector Laboratories, the Protein Detection business unit of Maravai Lifesciences Holdings Inc... 
Via Benzinga
News headline image
I-Mab Stock Flashes Vital Signs With 89 RS Rating ↗
I-Mab stock had its Relative Strength Rating upgraded from 70 to 89 on Wednesday. Is this biopharma stock on your radar? 
Via Investor's Business Daily
News headline image
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc... 
Via Benzinga
News headline image
Genmab Stock Flashes Healthy RS Rating ↗
Genmab stock just cleared an important benchmark with an RS Rating upgrade from 79 to 82. Is Genmab on your watchlist? 
Via Investor's Business Daily
News headline image
Mid-Afternoon Market Update: Dow Tumbles Over 400 Points; Virpax Pharmaceuticals Shares Spike Higher ↗
Toward the end of trading Tuesday, the Dow traded down 1.18% to 35,204.03 while the NASDAQ fell 1.24% to 14,610.77. The S&P also fell, dropping 1.06% to 4,432.01. The U.S. has... 
Via Benzinga
Topics Stocks
News headline image
The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 23) AbbVie Inc. (NYSE: ABBV) (... 
Via Benzinga
News headline image
Stock Market Near Highs, Treasury Yields Rally; Disney, Several IPOs Jump On Earnings ↗
Stocks traded at highs this week despite some growth wobbles. Treasury yields rebounded. Disney and some IPOs jumped on earnings. 
Via Investor's Business Daily
Topics Stocks
News headline image
Stocks That Hit 52-Week Highs On Monday ↗
Before 10 a.m. ET on Monday, 119 companies hit new 52-week highs. Noteables: The largest company by market cap to set a new 52-week high was Alphabet (NASDAQ:GOOG... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.